CombiGene AB Market Cap

CombiGene AB has a market cap or net worth of 47.72 million as of June 23, 2025. Its market cap has decreased by -26.97% in one year.

Market Cap

47.72M

Enterprise Value

-26.03M

Revenue

2.00M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.41

Market Cap Chart

Since May 25, 2015, CombiGene AB's market cap has decreased from 101.53M to 47.72M, a decrease of -53.00%. That is a compound annual growth rate of -7.21%.

Market Cap History

Date	Market Cap	% Change
Jun 23, 2025	47.72M	1.26%
Dec 30, 2024	47.13M	-11.52%
Dec 29, 2023	53.27M	-70.55%
Dec 30, 2022	180.88M	-19.87%
Dec 30, 2021	225.73M	43.52%
Dec 30, 2020	157.28M	120.80%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Swedish Orphan Biovitrum AB	95.07B
Sectra AB	63.97B
Getinge AB	49.73B
Asker Healthcare Group AB	40.95B
Medicover AB	35.63B
Camurus AB	34.56B
AddLife AB	22.85B
Vimian Group AB	21.48B

Market Cap Rankings